Conference Abstract
 
Navigation
Conference Abstracts Index

Abstracts - 2006 London

Abstracts - 2005 Zurich

Abstracts - 2004 Berlin

Abstracts - 2003 Barcelona

Abstracts - 2002 Brussels

Abstracts - 2001 Tokyo

Abstracts - 2000 Marburg

       

O#24   Comparative efficacy of oral finasteride and topical 2% minoxidil in male pattern baldness

D. Hugh Rushton. School of Pharmacy, University of Portsmouth, Portsmouth, UK

Hair variables obtained with the unit area trichogram in two double blind clinical trials employing topical 2% minoxidil were compared with values from subjects treated with oral finasteride (1.25mg.d-1). Thirty male subjects aged 18 and 52 years, with varying degrees of male pattern baldness were evaluated for total hair density (hair per cm2), useful hair density (hair longer than 3 cm per cm2) and per cent of hair in the anagen growth phase and after 12 months treatment with oral finasteride (n=15) or topical minoxidil (n=15). Compared to baseline no significant mean change in any hair variable could be found after 12 months of minoxidil therapy. In contrast, subjects treated with oral finasteride had an increase in total hair density (p = 0.06) and a significant increase (p < 0.01) in the percentage of hair in the anagen growth phase. Finasteride treated subjects matched for total hair density had a significant (p < 0.05) increase in useful hair density, with 53% achieving an increase of more than 15 hairs longer than 3 cm (1 inch) per cm2, compared with 13% using topical minoxidil. After 12 months of treatment the individual's subjective assessment of their hair found that 40% of the finasteride group but interestingly and indifferent to the objective data, 82% of the minoxidil treated group thought they had more hair compared with baseline.
Conclusion : Oral finasteride is significantly more effective than topical 2% minoxidil in the treating of male pattern baldness in men.